Rockwell Medical Inc (RMTI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Rockwell Medical Inc (Rockwell) is a biopharmaceutical company that focuses on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The companys major products include Triferic, an iron drug indicated for iron replacement and maintenance of hemoglobin during hemodialysis treatment; Calcitriol, a generic active vitamin D used to treat secondary hyperparathyroidism in dialysis patients; hemodialysis concentrates; dialysis kits; and ancillary products, among others. Its pipeline products are indicated for use in various applications including peritoneal dialysis, total parenteral nutrition and other iron deficiency anemia indications. The company markets its products through distributors in the US and through independent sales agents, direct sales force and distributors in overseas markets. Rockwell is headquartered in Wixom, Michigan, the US.

Rockwell Medical Inc (RMTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rockwell Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Rockwell Medical Inc, Medical Devices Deals, 2012 to YTD 2018 10
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deal Details 12
Licensing Agreements 12
Comercializadora BioRenal Enters into Licensing Agreement with Rockwell Medical 12
Quimica Europea Enters into Licensing Agreement with Rockwell Medical 13
ARAM Medical Enters into Licensing Agreement with Rockwell Medical 14
Wanbang Biopharma Enters into Licensing Agreement with Rockwell Medical 15
Equity Offering 16
Rockwell Medical Files Registration Statement for Public Offering of Shares for USD200 Million 16
Rockwell Medical Raises USD58.5 Million in Public Offering of Shares 17
Rockwell Medical Raises USD8 Million in Private Placement of Shares upon Exercise of Warrants 19
Rockwell Medical Technologies Completes Public Offering Of Shares For US$40.3 Million 20
Debt Offering 22
Rockwell Medical Completes Private Placement Of Debt Securities For US$20 Million 22
Rockwell Medical Inc - Key Competitors 23
Rockwell Medical Inc - Key Employees 24
Rockwell Medical Inc - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
May 10, 2018: Rockwell Medical Reports First Quarter 2018 Results 26
Mar 15, 2018: Rockwell Medical Reports Fourth Quarter and Year End 2017 Results 27
Nov 08, 2017: Rockwell Medical Announces Third Quarter Results 28
Aug 09, 2017: Rockwell Medical Reports Second Quarter Results 29
May 09, 2017: Rockwell Medical Reports First Quarter Results 30
Mar 15, 2017: Rockwell Medical Reports Fourth Quarter Results 31
Corporate Communications 32
May 22, 2018: Rockwell Medical Announces CEO Transition 32
Mar 13, 2018: Rockwell Medical Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors 34
Sep 07, 2017: Rockwell Medical Appoints John G. Cooper to Board of Directors 35
Mar 02, 2017: Rockwell Medical Announces Nomination of David Domzalski to Board of Directors 36
Product News 37
10/30/2017: Rockwell Medical Announces Two Triferic Poster Presentations at American Society of Nephrology Kidney Week 2017 Annual Meeting 37
06/07/2018: Rockwell Medical Provides Update on Commercial Strategy 38
05/02/2018: Rockwell Medical Announces Triferic Presentations at the 2018 International Congress on Peritoneal Dialysis 39
04/27/2017: Rockwell Medical Announces Poster Presentation and Oral Presentation on Triferic at the 7th Congress of the International BioIron Society May 7 11, 2017 40
04/10/2017: Rockwell Medical Announces Triferic Poster Presentations at the National Kidney Foundation Spring Clinical Meeting in Orlando 41
04/05/2018: Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings 42
03/20/2018: Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology 43
03/06/2017: Rockwell Medical Announces One Poster and Two Oral Presentations on Triferic at Annual Dialysis Conference March 11th-14th in Long Beach, CA 44
02/28/2018: Rockwell Medical Announces Triferic Presentations at the 2018 Annual Dialysis Conference 45
Clinical Trials 46
Jan 26, 2017: Rockwell Medical will Present Data on Triferic Intravenous (IV) Administration at the 19th International Conference on Dialysis in Las Vegas, February 1-3, 2017 46
Other Significant Developments 47
Jun 29, 2018: Rockwell Medical Provides Investor Update 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List Of Tables

List of Tables
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rockwell Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rockwell Medical Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Rockwell Medical Inc, Medical Devices Deals, 2012 to YTD 2018 10
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Comercializadora BioRenal Enters into Licensing Agreement with Rockwell Medical 12
Quimica Europea Enters into Licensing Agreement with Rockwell Medical 13
ARAM Medical Enters into Licensing Agreement with Rockwell Medical 14
Wanbang Biopharma Enters into Licensing Agreement with Rockwell Medical 15
Rockwell Medical Files Registration Statement for Public Offering of Shares for USD200 Million 16
Rockwell Medical Raises USD58.5 Million in Public Offering of Shares 17
Rockwell Medical Raises USD8 Million in Private Placement of Shares upon Exercise of Warrants 19
Rockwell Medical Technologies Completes Public Offering Of Shares For US$40.3 Million 20
Rockwell Medical Completes Private Placement Of Debt Securities For US$20 Million 22
Rockwell Medical Inc, Key Competitors 23
Rockwell Medical Inc, Key Employees 24
Rockwell Medical Inc, Subsidiaries 25

List Of Figures

List of Figures
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Rockwell Medical Inc, Medical Devices Deals, 2012 to YTD 2018 10

Rockwell Automation: Performance, Capabilities, Goals and Strategies in the Global Diversified Industrials Market

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

Rockwell Collins: Performance, Capabilities, Goals and Strategies in the Global Aerospace and Defense Market

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

Viveve Medical Inc (VIVE) - Medical Equipment - Deals and Alliances Profile

Viveve Medical Inc (Viveve Medical), formerly PLC Systems Inc, is a medical device company that develops womens health and wellness treatment solutions. The company offers non-prescription device to treat incontinence

USD 250 View Report

Shockwave Medical Inc - Medical Equipment - Deals and Alliances Profile

Shockwave Medical Inc (Shockwave) is a medical device provider for the treatment of advanced cardiovascular diseases. The company specializes in reshaping cardiovascular interventional therapy with intravascular lithotripsy (IVL) technology which

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available